CVRx (CVRX) Share-based Compensation Growth (3y) (2023 - 2026)
CVRx (CVRX) Share-based Compensation Growth (3y) (2023 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 4.10% |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 5.54% |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 5.09% |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 14.70% |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 5.29% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 7.15% |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 13.40% |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 12.36% |
| 10 | CVRx | 130.46 Mn | 58.16 Mn | 12.88 Mn | 19.59% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 19.59% |
| Dec 31, 2025 | 37.90% |
| Sep 30, 2025 | 45.95% |
| Jun 30, 2025 | 38.40% |
| Mar 31, 2025 | 45.74% |
| Dec 31, 2024 | 52.77% |
| Sep 30, 2024 | 78.15% |
| Jun 30, 2024 | 59.75% |
| Mar 31, 2024 | 467.37% |
| Dec 31, 2023 | 250.27% |
| Sep 30, 2023 | 266.97% |
| Jun 30, 2023 | 258.63% |